GRANDI, ANNA MARIA
 Distribuzione geografica
Continente #
NA - Nord America 19.852
EU - Europa 14.575
AS - Asia 8.255
SA - Sud America 979
AF - Africa 152
Continente sconosciuto - Info sul continente non disponibili 30
OC - Oceania 9
Totale 43.852
Nazione #
US - Stati Uniti d'America 19.654
IT - Italia 6.766
SG - Singapore 2.521
UA - Ucraina 2.510
CN - Cina 1.683
TR - Turchia 1.352
VN - Vietnam 1.325
SE - Svezia 1.295
HK - Hong Kong 921
DE - Germania 881
BR - Brasile 819
FI - Finlandia 797
IE - Irlanda 627
FR - Francia 597
GB - Regno Unito 492
RU - Federazione Russa 340
IN - India 145
MX - Messico 110
CA - Canada 67
AR - Argentina 63
BD - Bangladesh 62
JP - Giappone 61
NL - Olanda 53
PL - Polonia 49
NG - Nigeria 43
ZA - Sudafrica 38
BE - Belgio 36
ES - Italia 36
IQ - Iraq 33
EU - Europa 27
EC - Ecuador 23
ID - Indonesia 22
PK - Pakistan 22
AT - Austria 19
UZ - Uzbekistan 19
MA - Marocco 18
CL - Cile 16
PY - Paraguay 14
VE - Venezuela 14
JO - Giordania 13
KE - Kenya 13
LT - Lituania 13
TN - Tunisia 13
CH - Svizzera 12
CZ - Repubblica Ceca 12
SA - Arabia Saudita 12
CO - Colombia 11
CM - Camerun 9
PH - Filippine 9
AZ - Azerbaigian 7
PE - Perù 7
IL - Israele 6
NP - Nepal 6
PT - Portogallo 6
UY - Uruguay 6
AE - Emirati Arabi Uniti 5
AL - Albania 5
BO - Bolivia 5
BY - Bielorussia 5
DK - Danimarca 5
DZ - Algeria 5
EG - Egitto 5
MD - Moldavia 5
NZ - Nuova Zelanda 5
AU - Australia 4
OM - Oman 4
BB - Barbados 3
HN - Honduras 3
HU - Ungheria 3
IR - Iran 3
JM - Giamaica 3
KG - Kirghizistan 3
KZ - Kazakistan 3
QA - Qatar 3
TT - Trinidad e Tobago 3
AM - Armenia 2
BG - Bulgaria 2
CG - Congo 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
LB - Libano 2
MY - Malesia 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GA - Gabon 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
KR - Corea 1
LU - Lussemburgo 1
LV - Lettonia 1
Totale 43.840
Città #
Milan 5.023
Fairfield 2.053
Jacksonville 1.900
Ashburn 1.644
San Jose 1.545
Chandler 1.394
Singapore 1.387
Woodbridge 1.041
Hong Kong 909
Wilmington 875
Dearborn 794
Seattle 779
Houston 775
Cambridge 684
Izmir 675
Princeton 642
Dublin 628
Nyköping 544
Dallas 481
Beijing 468
Ann Arbor 403
Dong Ket 389
Boardman 341
Rome 338
The Dalles 289
Lauterbourg 275
San Mateo 266
Ho Chi Minh City 204
New York 194
Munich 186
San Diego 174
Chicago 170
Hanoi 165
Helsinki 154
Ogden 123
Orem 110
Los Angeles 105
Como 103
London 98
Düsseldorf 91
Santa Clara 81
Mexico City 77
Guangzhou 75
Hefei 68
São Paulo 68
Nanjing 64
Frankfurt am Main 63
Washington 63
Tokyo 61
Kunming 54
Verona 51
Turku 49
Chennai 46
Abuja 43
Norwalk 42
Redmond 42
Warsaw 39
Tianjin 38
Saint Petersburg 33
Shanghai 32
Amsterdam 30
Brussels 30
Jinan 30
Kocaeli 30
Manchester 30
Johannesburg 28
Shenzhen 28
Des Moines 27
Montreal 27
Rio de Janeiro 27
San Francisco 26
Brooklyn 25
Da Nang 25
Haiphong 25
Council Bluffs 24
Denver 24
Hangzhou 24
Nanchang 24
Berlin 23
Stockholm 23
Atlanta 22
Belo Horizonte 22
Zhengzhou 22
Buffalo 21
Boston 20
Nuremberg 20
Poplar 20
Mumbai 19
Columbus 18
San Giuliano Milanese 16
Ankara 15
Brasília 15
Fuzhou 15
Hebei 15
Phoenix 15
Redwood City 15
Shenyang 15
Curitiba 14
Auburn Hills 13
Changsha 13
Totale 30.383
Nome #
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature 372
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment 256
Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2 245
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment 244
Aldosterone antagonist improves diastolic function in essential hypertension 242
Blood pressure control and treatment adherence in hypertensive patients with metabolic syndrome: protocol of a randomized controlled study based on home blood pressure telemonitoring vs. conventional management and assessment of psychological determinants of adherence (TELEBPMET Study) 238
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis 234
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism 231
Right ventricular remodelling in mild hypertensive patients: role of left ventricular morpho-functional parameters 220
Ambulatory blood pressure, nocturnal blood pressure reduction and plasma catecholamines. 217
Imatinib discontinuation in chronic myeloid leukaemia patients with undetectable BCR-ABL transcript level: A systematic review and a meta-analysis 213
Ambulatory blood pressure, nocturnal blood pressure reduction and plasma catecholamines 210
Simvastatin down-regulates the production of Interleukin-8 by neutrophil leukocytes from dyslipidemic patients 207
Ambulatory blood pressure monitoring and atrial natriuretic peptide in normotensive and mild hypertensive subjects 204
Acute myeloid leukemia with associated translocation t(15;17) and 11q23/MLL abnormality 202
An unusual case presenting with hypertensive crisis. 201
Blockade of the renin-angiotensin-aldosterone system: effects on hypertensive target organ damage 198
Seasonal and monthly variation in occurrence of hypertensive urgency 198
Prolonged statin-associated reduction in neutrophil reactive oxygen species and angiotensin II type 1 receptor expression: 1-year follow-up 197
Pain perception, blood pressure levels, and peripheral benzodiazepine receptors in patients followed for differentiated thyroid carcinoma: a longitudinal study in hypothyroidism and during hormone treatment 196
sRAGE and early signs of cardiac target organ damage in mild hypertensives 196
Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature 195
Changes in plasma lipids during renin-angiotensin system blockade by combination therapy (enalapril plus valsartan)in patients with diabetes and hypertension 193
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature 193
24-hour blood pressare profile and left ventricular anatomy and function in untreated hypertensives with and without microalbuminuria 192
Validation of an easy questionnaire on the assessment of salt habit: the MINISAL-SIIA Study Program 192
Microalbuminuria in never-treated hypertensives: Relations with left ventricular characteristics, insulin sensitivity and genetic predisposition to hypertension. 191
In vitro effects of Apixaban on 5 different cancer cell lines 191
Effects of dual blockade of renin-angiotensin system on concentric left ventricular hypertrophy in essential hypertension: A randomized, controlled pilot study 189
Bone marrow necrosis related to imatinib mesylate therapy for cml bilineal blast crisis 188
Treatment with enalapril modifies the pain perception pattern in hypertensive patients. 188
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study 188
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis. 187
Alexithymia could mask depression in obese patients 183
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs 182
Aldosterone antagonist improves left ventricular diastolic function: a randomized, controlled study in essential hypertensives. 180
Acute neutrophil count is a predictor of worst short and long-term outcome in spontaneous intracerebral haemorrhage. 180
Relationship between a genetic predisposition to hypertension, blood pressure levels and pain sensitivity 178
POST-PRANDIAL GLYCEMIA DOES NOT INFLUENCE LEFT VENTRICULAR MORPHOLOGY AND FUNCTION IN NON-DIABETIC ESSENTIAL HYPERTENSIVES 177
Simvastatin treatment modifies polymorphonuclear leukocyte function in high-risk individuals: a longitudinal study 177
Angiotensin-converting enzyme inhibitors influence left ventricular mass and function independently of the antihypertensive effect 175
Tirosine kinase inhibitors adverse events 175
Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia 175
Isolated office hypertension: a 3 year follow-up study. 174
Lack of relationship between cardiovascular reactivity to mental stress and autonomic modulation of the sinoatrial node in normotensive and hypertensive male subjects 174
Family history of hypertension hyperinsulinemia and left ventricular function in lean and obese hypertensives 174
Laminar pattern of mineral calcium-phosphorus deposits in a human carotid plaque: nanoscale ultrastructure and elemental analysis 173
Acute neutrophil count is a predictor of worst short-and long-term outcome in spontaneous intracerebral haemorrahge 173
Genetic predisposition to hypertension influences left ventricular changes during antihypertensive therapy 172
Relationship between left ventricular diastolic function and atrial natriuretic factor in never-treated mild hypertensives. 172
OSA, metabolic syndrome and CPAP: Effect on cardiac remodeling in subjects with abdominal obesity. 172
24-hour non-invasive blood pressure monitoring and pain sensitivity 172
Matrix Metalloproteinases and their Inhibitors in Hypertensive Cardiac Remodelling 172
Abnormal response to handgrip in hypertensive patients with increased left ventricular mass, assessed by echocardiography. 171
Dyslipidemia in HIV-positive patients: a randomized, controlled, prospective study on ezetimibe+fenofibrate versus pravastatin monotherapy. 170
Circadian blood pressure variability is associated with autonomic and baroreflex-mediated modulation of the sinoatrial node 168
Obesity and left ventricular diastolic function: noninvasive study in normotensives and newly-diagnosed never-treated hypertensives. 168
Produzione di Tumor Necrosis Factor-a; e Interleuchina-4 dai linfociti circolanti e di Interleuchina-8 dai neutrofili in pazienti con sindrome delle apnee notturne: variazioni durante terapia notturna con pressione continua positiva nelle vie aeree. 167
Seasonal and monthly variation in occurrence of hypertensive urgency 167
Insulin sensitivity in obese normotensive adults: influence of family history of hypertension 166
Left ventricular anatomy and function in „white coat“ hypertensives: comparison with normotensives and never-treated ambulatory hypertensives. 166
Effects of sustained-release isradipine on left ventricular anatomy and function in systemic hypertension. 166
Noninvasive evaluation of cardiotoxicity of 5-fluorouracil and low doses of folinic acid: a one year follow-up study. 165
Glycemic control in type 2 diabetes mellitus : relationship with left ventricular diastolic dysfunction and matrix metalloproteinases 164
Mental stress test-induced changes in pain sensitivity and haemodynamic variables. 163
Left ventricular remodelling in asymptomatic HIV infection on chronic HAART: comparison between hypertensive and normotensive subjects with and without HIV infection. 163
New evidence on the potential role of the metabolic syndrome as a risk factor for venous thromboembolism. 162
Changes in pain perception during treatment with angiotensin converting enzyme-inhibitors and angiotensin II type 1 receptor blockade 162
Association of cardiomyopathy with Kugelberg-Welander disease. 162
Ambulatory monitoring in hypertensive patients: correlation between the first three hour elevation and the nocturnal pressure fall. 162
Natriuretic peptides as markers of preclinical cardiac disease in obesity 162
Cytokine production from peripheral blood mononuclear cells and polymorphonuclear leukocytes in patients studied for suspected obstructive sleep apnea. 161
Inibitore tessutale delle metalloproteasi (timp-1) in soggetti ipertesi lievi non trattati: ruolo nel rimodellamento cardiovascolare 161
Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature 161
The Hyper-Pract Study : a multicentre survey on the accuracy of the echocardiographic assessment of hypertensive left ventricular hypertrophy in clinical practice. 160
Masked hypertension in type 2 diabetes mellitus. Relationship with left-ventricular structure and function 160
Changes in Autonomic Modulation to the Heart and Intracellular Catecholamines. A Longitudinal Study in Differentiated Thyroid Carcinoma during Short-Term Hypothyroidism and Thyroid Hormone Replacement. 160
Systematic Review: Neutrophils and Clinical Outcomes in Patients With Acute Coronary Syndromes and/or Cardiac Revascularization. 160
Are Hypertensive Urgencies Prognostic factors for cardiovascular events? 160
AORTIC STIFFNESS IN NEVER - TREATED HYPERTENSIVES: LACK OF RELATION WITH MYOCARDIAL HYPERTROPHY AND IMPAIRED LEFT VENTRICULAR RELAXATION 159
Aldosterone antagonist improves left ventricular diastolic function: A randomized, controlled study in essential hypertension. 159
Relation of extent of nocturnal blood pressure decrease to cardiovascular remodeling in never-treated patients with essential hypertension. 159
Effect of glycemic control on left ventricular diastolic function in type 1 diabetes mellitus 158
Tumor necrosis factor-alpha and interleukin-4 production by circulating lymphocytes and interleukin-8 release by neutrophilis in patients with and without obstructive sleep apnea syndrome 158
Plasma matrix metalloproteinase (MMP)-9 and tissue inhibitor of MMPS (TIMP)-1 in hypertension: a meta-analysis. 158
CHRONIC TREATMENT WITH ACE-INHIBITORS INDUCES LEFT VENTRICULAR CHANGES INDEPENDENTLY OF BLOOD PRESSURE DECREASE 157
Left ventricular changes induced by chronic treatment with ACE-inhibitors independently of blood pressure effects 157
Systematic review: neutrophils and clinical outcomes in patients with acute coronary syndromes and/or cardiac revascularization. 157
Autonomic function and baroreflex sensitivity during a normal ovulatory cycle in humans. 157
Metabolic syndrome and morpho-functional characteristics of the left ventricle in clinically hypertensive nondiabetic subjects. 156
Indexing cardiac parameters in echocardiographic practice: do estimates depend on how weight and height have been assessed? A study on left atrial dilatation. 156
Left ventricular anatomy and function in normotensive young adults with hypertensive parents: study at rest and during handgrip. 156
l'inibitore tissutale delle metalloproteasi 1(timp-1) ed il danno d'organo cardiovascolare in pazienti con obesità addominale 156
Microalbuminuria as a marker of preclinical diastolic dysfunction in never-treated essential hypertensives. 155
Cytokine Production by Circulating Lymphocytes and Neutrophils in Patients with and without Obstructive Sleep Apnea Syndrome 155
Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study. 154
Hyperinsulinemia, family history of hypertension and essential hypertension 153
Chronic treatment with ace-inhibitors induces left ventricular changes independently of blood pressure decrease. 152
Mixed cranial nerve neuroma revealing itself as baroreflex failure 151
A case of possible pure hypoglycemic central pontine myelinolysis 151
Totale 18.049
Categoria #
all - tutte 166.837
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 166.837


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.423 0 0 0 0 0 0 0 0 0 242 429 752
2021/20223.361 288 474 296 280 148 72 141 223 197 488 291 463
2022/20233.649 410 188 238 408 281 871 3 450 567 78 72 83
2023/20247.726 1.289 1.213 1.368 1.486 1.385 569 33 94 201 18 20 50
2024/20254.113 23 63 756 74 154 251 227 317 397 285 318 1.248
2025/20268.824 779 589 451 1.322 754 669 2.256 577 1.036 391 0 0
Totale 44.050